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Objective. To determine the prevalence ofoccult HIV infection in patients who decline routine HIV testing in an urban emergency
department. D e s i g n ,S e t t i n g ,a n dP a t i e n t s . Discarded blood samples were obtained from patients who had declined routine ED
HIV testing. After insuring that the samples came from patients not known to be HIV positive, they were deidentiﬁed, and rapid
HIV testing was preformed using 5μL of whole blood. Main Outcome Measures. The prevalence of occult HIV infection in those
who declined testing compared with prevalence in those who accepted testing. Results. 600 consecutive samples of patients who
declined routine HIV screening were screened for HIV. Twelve (2%) were reactive. Over the same period of time, 4845 patients
accepted routine HIV testing. Of these, 35 (0.7%) were reactive. The diﬀerence in the prevalence of HIV infection between those
who declined and those who accepted testing was signiﬁcant (P = .001). The relative risk of undetected HIV infection in the
group that declined testing was 2.74 times higher (95% CI 1.44–5.18) compared with those accepted testing. Conclusion.T h er a t e
ofoccult HIV infection is nearly three-times higher in those who decline routine ED HIV testing compared with those who accept
such testing. Interventions are urgently needed to decrease the opt-out rate in routine ED HIV testing settings.
1.Introduction
The Centers for Disease Control and Prevention (CDC) has
estimated that approximately 1–1.2 million people in the US
are infected with HIV. Of these, one-quarter are unaware of
their infection [1, 2]. In 2006, the CDC recommended that
routine HIV screening be expanded to many outpatient set-
tings including emergency departments (EDs). Speciﬁcally,
the CDC recommended that screening for HIV infection be
routinely performed for all patients aged 13–64, in settings
where the prevalence of undiagnosed HIV infection in the
patientpopulation is more than 0.1%[3]. The CDCalso rec-
ommendedthattestingprogramsuseanopt-outapproachin
which patients are informed that the test will be done unless
they decline. Several emergency departments have instituted
these recommendations, including The George Washington
University Hospital (GWUH), which began to oﬀer routine
opt-out ED HIV testing in September 2006 [4, 5]. Since
the program’s inception, the GWUH-ED has oﬀered free
rapid HIV testing to over 32,000 individuals. Approximately
44% of eligible patients decline an ED HIV test, and the
HIV seroprevalence rate among those who accepted testing
is 0.7% [4, 6]. Our prior work demonstrated that the main
reason patients declined routine ED HIV screening is that
they did not believe they were at risk for HIV infection [7].
Wehypothesized thatpatientsunderestimatetheirHIVrisks,
and that the rate of undetected HIV in patients who decline
testing would be as high as the rate in those who accept the
test. We, therefore, performed a study to compare the HIV
seroprevalence rate of individuals who declined routine ED
testing with that of patients who accepted testing.
2.Materialsand Methods
This cross-sectional study was performed at The George
Washington University Hospital Emergency Department
in Washington, DC. The George Washington University2 AIDS Research and Treatment
Hospital is a 370-bed, urban, tertiary care center and a level-
1 trauma center located in Washington DC where the HIV
seroprevalence is approximately 3% [8]. The ED census is
62,000 patient visits per year. In 2006, the GWU ED imple-
mented an opt-out, nontargeted HIV screening program in
response to CDC guidelines on non-targeted HIV screening.
Characteristics of this program have been described in detail
elsewhere [4, 6]. In brief, a patient was eligible for ED HIV
screening if he or she was aged 18–64, was not known to be
HIVpositive,wasabletocommunicatewith thescreenerand
had a normal mental status, had not been tested within the
prior three months, and had no urgent medical condition
that required immediate intervention. HIV screening was
performed by dedicated additional screening staﬀ available
24 hours a day, using the OraQuick Advance Rapid HIV-1/2
Antibody Test (OraSure Technologies, Inc, Bethlehem, PA).
The typeof HIVscreening test made available for clinicaluse
was both determined and provided by the HIV/AIDS, Hep-
atitis, STD, and TB Administration in the DC Department
of Health. The screeners reviewed the ED electronic medical
record for eligible patients. Once a patient was determined
to be eligible for a test, he or she was informed by the
screeners that they would be tested unless they declined the
test. There was no pretest counseling, and written informed
consent was not required. Preliminary HIV test results were
recorded in the patient’s electronic medical record in the
ED. Western blot conﬁrmatory testing was conducted for all
preliminary positives among those who accepted screening.
The prevalence of HIV infection in those who accepted the
test was calculated as the number of conﬁrmed positive tests
divided by the number of unique patients who accepted
screening during the study period.
To estimate the HIV prevalence among emergency
department patients who declined HIV screening, discarded
blood samples were collected daily between July 26, 2008
and March 26, 2009. These samples had been collected for
diagnostic testing but were no longer needed. The discarded
s a m p l e sw e r ei n c l u d e di nt h i sa n a l y s i si ft h e ym e tt h e
following criteria: (1) they belonged to a patient who was
oﬀered and refused HIV screening in the ED and (2) the
sample was collected in an appropriate container (lithium
heparin, sodium citrate, or EDTA). To insure that these
samples did not contain patients who were known to be
HIV positive, two steps were taken. Firstly, the name on each
sample was checked against a database of patients who had
previously been oﬀered a routine HIV screening test. If the
patient had taken the test and was positive, the sample was
excluded. Secondly, the name was checked against all prior
ED visits (going back to 2004) for evidence of known HIV
infection, such as a report of the disease in the patient’s
medical history, a positive conﬁrmatory test for HIV, or the
presence of any antiretroviral medication in the list of the
patient’s medications. The sample was excluded if there were
any of these ﬁndings.
Demographic data for patients who accepted or declined
thetestwereobtainedfromtheEDelectronicmedicalrecord.
In addition, the patient’s reason for declining testing was
recorded. After this initial data was collected, the identifying
patient label was removed from the blood sample, and
identifying information was deleted from the electronic
database. The sample and the de-identiﬁed database entry
were then linked with a unique study identiﬁcation number.
HIV screening was performed with 5μL of whole blood
using the OraQuick Advance Rapid HIV-1/2 Antibody Test,
the same test that was used for patients who accepted
screening.
All patients signed a consent form permitting de-
identiﬁed discarded blood samples to be used for scientiﬁc
purposes, and the study was approved by the Institutional
Review Board at the George Washington University Medical
Center.
The sample size calculation was based on assumptions of
the expected HIV prevalence in both groups. With α = 0.05
andapowerof0.8,590sampleswouldbeneededifthepreva-
lence was 1% in the patients who accepted testing and 3% in
those who declined, assuming at least 2,500 patients were in
thegroupthatacceptedtesting.Demographiccharacteristics,
including age, sex, race, and insurance status of the acceptors
and the decliners were compared using Chi-square tests.
3.Results
During the study period, 7,558 patients met eligibility cri-
teria for routine screening, of whom 4,845 (64%) accepted
testingand2,713individualsdeclined.Ofthosewhodeclined
testing, we identiﬁed 28 patients who were already known
to be HIV positive. From the remaining 2,685 patients, we
screened 600 consecutive patients who also had a discarded
blood sample (see Figure 1). The demographic character-
istics of all individuals oﬀered HIV testing in the ED are
presented in Table 1. There were no signiﬁcant diﬀerences in
age, race, or insurance status between those who agreed to be
tested and those who declined.
Ofthe600samplesanalyzed,12(2%)werereactive,com-
pared with 35 (0.7%)reactive samplesin the groupaccepting
HIV screening during the same period (P = .001). The
relative risk of occult HIV infection in the group that
declined testing was 2.74 (95% CI 1.44–5.18) compared to
the group that accepted testing (see Table 1). There was a
signiﬁcant diﬀerencein the gendersof those who were found
to be HIV positive between the two groups. In the group
that accepted HIV screening, 20% (7/35) of the seropositive
individuals were women; in the group that declined testing,
67% (8/12) of those who were seropositive were women
(P<. 05, see Table 2). Being nonwhite was associated with
declining testing and having a positive HIV test (Table 3).
The most common reason for declining testing was the
patient’s belief he or she was not at risk. Of the 600 samples
from patients who declined testing, 49% stated the reason
for not testing was “I am not at risk” (Table 2). Among those
who declined testing and had a positive screen, one-third
(4/12) stated that they were not at risk (Table 2).
4.Discussion
In this ED HIV screening program, patients who declined
testinghadapositivityrateof2%,almostthree-timestherate
of those who accepted the test during the same time period.AIDS Research and Treatment 3
7558 patients oﬀered an ED HIV test
4845 accepted testing 2713 declined testing
28 identiﬁed as
known HIV positive
2685 patients not known to be
HIV positive
600 discarded blood samples
available for analysis
35 positives
(0.7%)
12 positives
(2.0%)
Study ﬂow
July 2008–March 2009
Figure 1: Study ﬂow.
Althoughwe believeoursistheﬁrst studyofitstype,data
from women who opt out of prenatal HIV screening sup-
ports our conclusions. In one study, between 3.6 and 4.3%
of pregnant women declined an HIV screening test, and the
seroprevalence of HIV in this group was found to be 3.3-
times higher than the HIV seroprevalence among pregnant
women who accepted the screening test [9]. Individuals
who decline a routine HIV screening and who may assume
that they have little risk of HIV infection appear to be at
considerably greater risk than they believe.
There are several explanations for ourﬁnding. It is possi-
ble that some of the patients who declined testing actually
knew they were HIV positive, but were uncomfortable in
reporting this information. For this reason, they stated they
were not at risk when asked why they declined a test. While
we cannot completely exclude this possibility, we believe it is
unlikely. ED patients are always asked about any underlying
medical conditions, and for a list of the medications that
they are taking. This information is gathered by the nurse
at triage, and is reviewed by the treating physician who asks
againaboutpriormedicalconditionsandmedications.These
details are recorded on the ED electronic medical record, and
in our experience patients are generally forthcoming about
their medical history, including a history of HIV infection.
We attempted to minimize the possibility of including a
patient who had not shared their HIV-positive status by
reviewing all the available medical records for any reference
to HIV infection, before determining that a patient was not
known to be HIV positive.
Another possibility is that patients who declined a
screening test were actually aware of their own increased
risk of HIV infection, but did not wish be tested for fear4 AIDS Research and Treatment
Table 1: Demographic characteristics and HIV seroprevalence among HIV test acceptors and decliners.
Characteristic Total (%) Acceptors (%) Decliners (%) X2
N = 5445 n = 4845 n = 600 P value
Age
<35 years old∗ 3040 (55.8) 2784 (57.5) 256 (42.6) <.001
≥35 years old 2405 (44.2) 2061 (42.5) 344 (57.4)
Gender
Male∗ 2182 (40.1) 1969 (40.6) 215 (35.7) .07
Female 3262 (59.9) 2875 (59.4) 385 (64.3)
Transgender 1 (0.0) 1 (0.0) 0 (0.0)
Race
White∗ 1810 (33.3) 1566 (32.4) 244 (40.7) <.001
Black 3089 (56.9) 2794 (57.8) 295 (49.2)
Asian 75 (1.4) 62 (1.3) 13 (2.2)
Other 278 (5.1) 253 (5.2) 25 (4.2)
Do not know/unsure 193 (3.3) 170 (3.3) 23 (3.7)
Insurance
Private∗ 2812 (51.8) 2694 (55.7) 118 (19.7) <.001
Public 735 (13.5) 340 (7.0) 395 (65.9)
None/self-pay 506 (9.3) 492 (10.2) 14 (2.3)
Unknown/other 1392 (25.4) 1319 (27.1) 73 (12.0)
HIV test result
Positive 47 (0.9) 35 (0.7) 12 (2.0) .001
∗Comparison used to determine P value.
Table 2: Reason for declining an HIV test.
Total Age Race∗ Gender
Reason N = 600
%
<35 years
n = 256
%
≥35 years
n = 344
%
White
n = 244
%
Non-white
n = 356
%
Male
n = 215
%
Female
n = 385
%
Not at risk 49.2 54.5 45.5 40.3 62.3 46.3 50.9
Recently tested
(but more than 3 months prior) 14.2 12.6 15.5 17.5 9.4 13.6 14.6
Would rather be tested
somewhere else 3.0 2.8 3.2 3.1 2.9 2.3 3.4
Afraid to get result 2.3 3.1 1.8 3.4 0.8 2.8 2.1
No time in the ED 0.8 0.4 0.9 0.9 0.8 0.9 0.8
No reason given 26.7 22.8 29.7 31.3 20.1 30.8 24.4
Other 3.7 3.9 3.5 3.7 3.7 3.3 3.9
∗P<. 001.
of learning their status. These patients, therefore, declined
testing, and oﬀered a reason that they felt to be the most
socially acceptable. This phenomenon, known as social
desirability bias, is well described in the literature and may
apply to this cohort of patients [10].
Anotherconsiderationisthat patientswho are more seri-
ously ill are more likely to have blood drawn during their ED
visit.Thiswouldleadtosickerpatientsbeingoverrepresented
in the discarded blood samples when compared with the
cohort of patients who accept an HIV screening test. Since
the entire cohort of patients we tested did have blood drawn,
they may as a whole have been sicker than patients in the
comparator group. Since we did not record which patientsin
the comparator group had blood drawn, we cannot evaluate
this possibility further.
Many HIV-infected persons learn about their diagnosis
years after initial infection [11]. Missed opportunities for
HIV testing occur in medical settings frequently, and it
has been shown that there is a high rate of undiagnosed
HIV infection among the patient population seen in urban
emergencydepartments [12, 13]. The 2006CDCrecommen-
dationsaimedtoincreaseroutineHIVtestinginmedicalcare
tohelpidentifypreviouslyundiagnosedHIVinfectionearlier
in their disease. As these recommendations have slowly beenAIDS Research and Treatment 5
Table 3: HIV seropositivity among decliners by age, race, gender,
and main reasons for declining (n = 600).
Characteristic HIV negative
n = 588
HIV positive
n = 12 P-value∗
Age
<35 years old 253 (98.4) 4 (1.6) .57
≥35 years old 335 (97.7) 8 (2.3)
Race
White 244 (99.6) 1 (0.4) .03
Non-white 344 (96.9) 11 (3.1)
Gender
Male 211 (98.1) 4 (1.9) 1.00
Female 377 (97.9) 8 (2.1)
Felt was not at risk for
HIV
Yes 297 (97.4) 8 (2.6) .38
No 291 (98.6) 4 (1.4)
Recently tested
Yes 505 (98.1) 10 (1.9) .68
No 83 (97.7) 2 (2.3)
Would rather test
somewhere else
Yes 296 (97.4) 8 (2.6) .31
No 292 (98.6) 4 (1.4)
∗Fisher’s exact test due to cell sizes <5.
implemented, it has been noted that the incidence of HIV
infection is highest among racial and ethnic minorities who
have poor access to healthcare and frequently utilize the ED
as their predominant source of health care [12]. Most of
these patients with undiagnosed HIV infection, present to
the ED for reasons unrelated to their infection. As a result, it
ispreciselythosepatientswhoareatagreaterriskofinfection
who are most likely to go undetected early in the course of
their HIV disease [14].
Our ﬁnding of a high rate of HIV infection among
women who decline testing is of great concern. These
women, by virtue of their belief that they are not infected
m a yb em o r el i k e l yt oe n g a g ei na d d i t i o n a lr i s k yb e h a v i o r
and contribute to the spread of the HIV virus. Women in
particular appear to be at increased risk for having HIV
infection yet underestimate their risk [15]. These ﬁndings
parallel the recent assessment of the changing face of the
HIV epidemic in the District of Columbia conducted by
DC DOH and George Washington School of Public Health
[16]. Although blacks, other nonwhites, and patients under
the age of 50 had high rates of unrecognized infection and
underestimated risk, the greatest increase in incidence was
among African-American women.
In conclusion,this study demonstrated that patients who
decline routine HIV screening in an emergency department
inahighprevalenceareaareatahigherriskofinfectioncom-
pared with those who accept testing. Although routine HIV
testing inthe EDhas beenshown tobean eﬀectivestrategy at
identifying HIV infections in the community [6, 12, 17, 18],
screening ultimately depends on the patient’s willingness to
accept the test. We suggest that interventions be targeted
at those who decline routine testing and especially to black
women, who may be signiﬁcantly underestimating their risk
of infection.
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